MGB Biopharma Limited is a biopharmaceutical company established to develop a completely new class of anti-infective medicines based upon compounds which are DNA Minor Groove Binders (MGB)
The company has an exceptionally experienced team from both pharma and biotech sectors and is dedicating its focus initially to the development of small molecules with specific antibacterial efffects against resistant bacteria
By selecting a new class of antibacterial, the company believes the novel mode of action should prove to be very potent against bacteria as these target organisms will lack any inherent resistance, unlike that typically facing new drugs which are the result of modifications from existing classes of drugs used to treat bacterial infection
Funding Rounds (3) - $11.6MUpdate
Investment Arm of Scottish Enterprise
Tweed Renaissance Investors Capital
Glasgow Venture Capital
Introducing Investors To Opportunities
Technology Strategy Board is to stimulate technology-enabled innovation in the areas which offer...
With investment deals valued at more than Â£3 million under its belt, Tweed Renaissance Investors...
151 West George Street
Snodland, G2 2JJ